Mathieu Simon
Chairman presso IDORSIA LTD
Patrimonio netto: 263 805 $ in data 31/03/2024
Profilo
Mathieu Simon è presidente di Epsilen Bio SRL, presidente di Idorsia Ltd., amministratore indipendente di Asarina Pharma AB, amministratore indipendente di Vaximm AG, presidente di Idorsia Pharmaceuticals Ltd., amministratore delegato di Cellectis Therapeutics e amministratore indipendente di LNC Therapeutics SA. Fa parte del Consiglio di amministrazione di Lysogene SA, Asarina Pharma AB, Affimed NV, Affimed GmbH, Vaximm AG, Messier Maris & Associs SCA e LNC Therapeutics SA. Il Dr. Simon è stato precedentemente impiegato come EVP, Chief Operating & Medical Officer di Cellectis SA, Vicepresidente di Marketing & Medical Affairs di Wyeth Pharmaceuticals LLC, Group VP-Marketing & Clinical Affairs di Wyeth-Ayerst International, Inc., Senior Vice President-Global Operations di Pierre Fabre Mdicament SAS, Managing Director & Head-Global Pharma di Pierre Fabre SA e Chairman & Chief Executive Officer di Takara Bio Europe AB. È stato anche membro del consiglio di amministrazione di Alliance for Regenerative Medicine, Ectycell SASU e Farmindustria.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
IDORSIA LTD.
0.03% | 31/12/2022 | 65 452 ( 0.03% ) | 205 505 $ | 31/03/2024 |
AFFIMED N.V.
0.07% | 15/03/2023 | 11 000 ( 0.07% ) | 58 300 $ | 31/03/2024 |
Posizioni attive di Mathieu Simon
Società | Posizione | Inizio |
---|---|---|
AFFIMED N.V. | Director/Board Member | 19/06/2018 |
IDORSIA LTD | Chairman | 13/05/2020 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Chairman | 13/05/2020 |
Messier Maris & Associés SCA
Messier Maris & Associés SCA Investment ManagersFinance Messier Maris & Associés SCA provides financial consulting and investment advisory services. The company was founded by Jean-Marie Messier and Erik Maris in 2010 and is headquartered in Paris, France. | Director/Board Member | - |
Epsilen Bio Srl
Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy. | Chairman | 15/06/2020 |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Director/Board Member | 01/01/2018 |
Aileens Pharma Srl
Aileens Pharma Srl Miscellaneous Commercial ServicesCommercial Services Aileens Pharma Srl is a holding company, which engages in the research and development of treatments for dermatological diseases. The company was founded by Sonia Longo Sormani in 2018 and is headquartered in Nova Milanese, Italy. | Chairman | - |
Precedenti posizioni note di Mathieu Simon
Società | Posizione | Fine |
---|---|---|
CELLECTIS S.A. | Chief Tech/Sci/R&D Officer | 14/03/2018 |
Cellectis Therapeutics | Chief Executive Officer | 01/02/2014 |
░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Mathieu Simon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
AFFIMED N.V. | Health Technology |
CELLECTIS S.A. | Health Technology |
ASARINA PHARMA AB | Health Technology |
LYSOGENE | Commercial Services |
IDORSIA LTD | Health Technology |
Aziende private | 17 |
---|---|
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
Pierre Fabre Médicament SAS
Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Université Paris Diderot-Paris 7 | Consumer Services |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
Messier Maris & Associés SCA
Messier Maris & Associés SCA Investment ManagersFinance Messier Maris & Associés SCA provides financial consulting and investment advisory services. The company was founded by Jean-Marie Messier and Erik Maris in 2010 and is headquartered in Paris, France. | Finance |
Ectycell SASU
Ectycell SASU BiotechnologyHealth Technology Ectycell SASU produces and sales stem cells. It offers pluripotent stem cells that can be used to develop drugs and model diseases. The company was founded in September 2009 and is headquartered in Romainville, France. | Health Technology |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Health Technology |
Wyeth-Ayerst International LLC | |
Farmindustria
Farmindustria Miscellaneous Commercial ServicesCommercial Services Farmindustria is an association of pharmaceutical companies that are based in Italy. The private company provides an interactive map that shows the location of their offices, production sites, and research centers. Farmindustria is located in Rome, Italy. The Italian company promotes the value of the pharmaceutical industry in terms of employment, investment, innovation, research and development, production, and export. The company also provides updates on COVID-19 and information on the pharmaceutical industry. | Commercial Services |
Aileens Pharma Srl
Aileens Pharma Srl Miscellaneous Commercial ServicesCommercial Services Aileens Pharma Srl is a holding company, which engages in the research and development of treatments for dermatological diseases. The company was founded by Sonia Longo Sormani in 2018 and is headquartered in Nova Milanese, Italy. | Commercial Services |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Health Technology |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Commercial Services |
Epsilen Bio Srl
Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy. | Health Technology |
Cellectis Therapeutics | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Mathieu Simon